MedPath

Impact of Multidisciplinary Review of Drug Prescriptions on Patient Safety in a Residence for Dependent Elderly

Not Applicable
Completed
Conditions
Health Services for the Aged
Geriatrics
Residence for Dependent Elderly
Interventions
Other: Before-after study
Registration Number
NCT02118259
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The main objective of the study is to show that the multidisciplinary review of drug prescriptions changes the adverse drug event (ADE) geriatric risk score (according to Trivalle and Ducimetière 2013) for patients living in the Nîmes University Hospital Residence for Dependent Elderly.

Detailed Description

The secondary objectives of this study are to assess and compare the following criteria before and after multidisciplinary review of drug prescriptions for patients in the Nîmes University Hospital Residence for Dependent Elderly:

A. the number of patients with at least one potentially inappropriate drug prescribed

B. the number of hospitalizations

C. death rate

D. the number of falls per patient and the rate of fallers

E. qualitative criteria describing the drug review

F. associated care costs

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • The patient (or his/her legal representative) must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 6 months of follow-up
  • The patient has resided at the Nîmes University Hospital Residence for Dependent Elderly for at least the past 6 months
Exclusion Criteria
  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection
  • The patient (or his/her legal representative) refuses to sign the consent
  • It is impossible to correctly inform the patient (or his/her legal representative)
  • The patient has resided at the Nîmes University Hospital Residence for Dependent Elderly for less than 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
The study populationBefore-after studySee inclusion and exclusion criteria. Intervention: Before-after study
Primary Outcome Measures
NameTimeMethod
Adverse Drug Events Geriatric Risk Scorechange from Baseline to 6 months

according to Trivalle and Ducimetière 2013

Secondary Outcome Measures
NameTimeMethod
The number of patients taking at least 1 potentially inappropriate drug according to Laroche criteriaDuring the proactive phase. Day 0.

Laroche et al 2007.

Number of hospitalizations in the public sector (higher level care)second observational phase (day 0 to month 6)
Days of hospitalization in the public sector (higher level care)second observational phase (day 0 to month 6)
Mortalitysecond observational phase (day 0 to month 6)
The number of falls per patientsecond observational phase (day 0 to month 6)
The percentage of patients who fellsecond observational phase (day 0 to month 6)
The Anatomical Therapeutic Chemical classification for each revised drugduring the proactive phase (day 0)
The type of errors detected during drug reviewduring the proactive phase (day 0)

Contra-indication, dosing, route, etc

The type of modification suggested during drug reviewduring the proactive phase (day 0)

discontinuation, addition, substitution...

The acceptation rate for modifications suggested during drug reviewduring the proactive phase (day 0)
Associated care costs (€)second observational phase (day 0 to month 6)

Trial Locations

Locations (2)

CHRU de Nîmes - Hôpital Universitaire Carémeau

🇫🇷

Nîmes Cedex 09, France

CHRU de Nîmes - Centre de Gérontologie de Serre Cavalier

🇫🇷

Nîmes, France

© Copyright 2025. All Rights Reserved by MedPath